This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2015 Apr 28;313(16):1671-2.

doi: 10.1001/jama.2015.3075.

Proportion of adults with sickle cell anemia and pain crises receiving hydroxyurea

Nicolas Stettler¹, Colleen M McKiernan¹, Court Q Melin¹, Oluwakayode O Adejoro¹, Nancy B Walczak¹

Affiliations

PMID: 25919532
DOI: 10.1001/jama.2015.3075

Proportion of adults with sickle cell anemia and pain crises receiving hydroxyurea

Nicolas Stettler et al. JAMA. 2015.

. 2015 Apr 28;313(16):1671-2.

doi: 10.1001/jama.2015.3075.

Authors

Nicolas Stettler¹, Colleen M McKiernan¹, Court Q Melin¹, Oluwakayode O Adejoro¹, Nancy B Walczak¹

Affiliation

¹ The Lewin Group, Falls Church, Virginia.

PMID: 25919532
DOI: 10.1001/jama.2015.3075

No abstract available

PubMed Disclaimer

Similar articles

The association between hydroxyurea adherence and opioid utilization among Texas Medicaid enrollees with sickle cell disease.
Kang HA, Barner JC. Kang HA, et al. J Manag Care Spec Pharm. 2020 Nov;26(11):1412-1422. doi: 10.18553/jmcp.2020.26.11.1412. J Manag Care Spec Pharm. 2020. PMID: 33119448 Free PMC article.
Provider barriers to hydroxyurea use in adults with sickle cell disease: a survey of the Sickle Cell Disease Adult Provider Network.
Lanzkron S, Haywood C Jr, Hassell KL, Rand C. Lanzkron S, et al. J Natl Med Assoc. 2008 Aug;100(8):968-73. J Natl Med Assoc. 2008. PMID: 18717150
A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.
Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP; Investigators of the Phase 3 Trial of l-Glutamine in Sickle Cell Disease. Niihara Y, et al. N Engl J Med. 2018 Jul 19;379(3):226-235. doi: 10.1056/NEJMoa1715971. N Engl J Med. 2018. PMID: 30021096 Clinical Trial.
Hydroxyurea for the treatment of sickle cell anemia.
Platt OS. Platt OS. N Engl J Med. 2008 Mar 27;358(13):1362-9. doi: 10.1056/NEJMct0708272. N Engl J Med. 2008. PMID: 18367739 Review. No abstract available.
Approach to the vaso-occlusive crisis in adults with sickle cell disease.
Yale SH, Nagib N, Guthrie T. Yale SH, et al. Am Fam Physician. 2000 Mar 1;61(5):1349-56, 1363-4. Am Fam Physician. 2000. PMID: 10735342 Review.

See all similar articles

Cited by

A Pharmacist-Managed Hydroxyurea Prescribing Protocol Improves Uptake and Optimization among Patients with Sickle Cell Disease.
Roessner C, Sale T, Uminski K, Goodyear D, Rydz N. Roessner C, et al. Adv Hematol. 2024 May 30;2024:4753349. doi: 10.1155/2024/4753349. eCollection 2024. Adv Hematol. 2024. PMID: 38912090 Free PMC article.
A Mixed-Methods Evaluation of a Project ECHO Program for the Evidence-Based Management of Sickle Cell Disease.
Mosley C, Farrell CB, Quinn CT, Shook LM. Mosley C, et al. Int J Environ Res Public Health. 2024 Apr 25;21(5):530. doi: 10.3390/ijerph21050530. Int J Environ Res Public Health. 2024. PMID: 38791745 Free PMC article.
In vitro delayed response to dihydroartemisinin of malaria parasites infecting sickle cell erythocytes.
Gnondjui AA, Toure OA, Ako BA, Koui TS, Assohoun SE, Gbessi EA, N'Guessan LT, Tuo K, Beourou S, Assi SB, Yapo FA, Sanogo I, Jambou R. Gnondjui AA, et al. Malar J. 2024 Jan 4;23(1):9. doi: 10.1186/s12936-023-04819-5. Malar J. 2024. PMID: 38178227 Free PMC article.
Use of Disease-Modifying Treatments in Patients With Sickle Cell Disease.
Newman TV, Yang J, Suh K, Jonassaint CR, Kane-Gill SL, Novelli EM. Newman TV, et al. JAMA Netw Open. 2023 Nov 1;6(11):e2344546. doi: 10.1001/jamanetworkopen.2023.44546. JAMA Netw Open. 2023. PMID: 37991760 Free PMC article.
Society for Maternal-Fetal Medicine Consult Series #68: Sickle cell disease in pregnancy.
Society for Maternal-Fetal Medicine; Sinkey RG, Ogunsile FJ, Kanter J, Bean C, Greenberg M; Society for Maternal-Fetal Medicine Publications Committee. Electronic address: pubs@smfm.org. Society for Maternal-Fetal Medicine, et al. Am J Obstet Gynecol. 2024 Feb;230(2):B17-B40. doi: 10.1016/j.ajog.2023.10.031. Epub 2023 Oct 21. Am J Obstet Gynecol. 2024. PMID: 37866731 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- H1 Connect
- The Lens - Patent Citations Database
Medical
- Genetic Alliance
- MedlinePlus Health Information